Moors & Cabot’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$609K Sell
9,313
-460
-5% -$31.1K 0.02% 513
2026
Q2
$626K Sell
9,773
-3,379
-26% -$222K 0.02% 506
2026
Q1
$936K Sell
13,152
-1,359
-9% -$107K 0.04% 387
2025
Q4
$1.19M Sell
14,511
-2,562
-15% -$200K 0.05% 314
2025
Q3
$1.28M Buy
17,073
+7,531
+79% +$562K 0.06% 302
2025
Q2
$707K Buy
9,542
+374
+4% +$26K 0.03% 419
2025
Q1
$740K Sell
9,168
-607
-6% -$52.2K 0.04% 385
2024
Q4
$764K Sell
9,775
-125
-1% -$10.6K 0.04% 391
2024
Q3
$929K Sell
9,900
-64
-0.6% -$5.37K 0.05% 350
2024
Q2
$776K Sell
9,964
-4,434
-31% -$362K 0.04% 363
2024
Q1
$1.31M Sell
14,398
-6,115
-30% -$509K 0.07% 249
2023
Q4
$1.59M Buy
20,513
+133
+0.7% +$9.31K 0.1% 195
2023
Q3
$1.39M Buy
20,380
+2,713
+15% +$197K 0.09% 207
2023
Q2
$1.44M Buy
17,667
+2,282
+15% +$182K 0.1% 206
2023
Q1
$1.26M Buy
+15,385
New +$1.1M 0.09% 231

Other funds holding GEHC

Moors & Cabot's GEHC Position: Q3 2026 in Review

Moors & Cabot reduced its GE HealthCare (GEHC) stake by 4.7% in Q3 2026, selling an estimated $31.1K and leaving 9,313 shares worth $609K. The position accounts for 0.02% of the portfolio, ranked #513.

Moors & Cabot first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $1.59M in Q4 2023. 744 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Moors & Cabot held 9,313 shares of GE HealthCare worth $609K as of Q3 2026.
  • Moors & Cabot sold 460 GE HealthCare shares in Q3 2026, an estimated $31.1K.
  • GE HealthCare made up 0.02% of Moors & Cabot's portfolio in Q3 2026, its #513 holding.
  • Moors & Cabot first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Moors & Cabot's GE HealthCare position peaked at $1.59M in Q4 2023.
  • 744 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.